Back to Search
Start Over
One-year safety and efficacy of mitapivat in sickle cell disease:follow-up results of a phase 2, open-label study
- Source :
- van Dijk , M J , Rab , M A E , van Oirschot , B A , Bos , J , Derichs , C , Rijneveld , A W , Cnossen , M H , Nur , E , Biemond , B J , Bartels , M , Jans , J J M , van Solinge , W W , Schutgens , R E G , van Wijk , R & van Beers , E J 2023 , ' One-year safety and efficacy of mitapivat in sickle cell disease : follow-up results of a phase 2, open-label study ' , Blood Advances , vol. 7 , no. 24 , pp. 7539-7550 .
- Publication Year :
- 2023
Details
- Database :
- OAIster
- Journal :
- van Dijk , M J , Rab , M A E , van Oirschot , B A , Bos , J , Derichs , C , Rijneveld , A W , Cnossen , M H , Nur , E , Biemond , B J , Bartels , M , Jans , J J M , van Solinge , W W , Schutgens , R E G , van Wijk , R & van Beers , E J 2023 , ' One-year safety and efficacy of mitapivat in sickle cell disease : follow-up results of a phase 2, open-label study ' , Blood Advances , vol. 7 , no. 24 , pp. 7539-7550 .
- Notes :
- application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1481683459
- Document Type :
- Electronic Resource